Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 02:30:02 24/01/2026 am IST			5-day change	1st Jan Change
220.14 ^USD	+0.76%		+0.68%	+6.37%

24/01	Argus Raises Price Target on Johnson & Johnson to $240 From $210	MT
23/01	Bernstein Adjusts Price Target on Johnson & Johnson to $225 From $208, Maintains Market Perform Rating	MT

Transcript : Johnson & Johnson Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-17-2025 10

Published on 11/17/2025 at 10:35 pm IST - Modified on 11/18/2025 at 12:05 am IST

S&P Capital IQ

Presenter Speech
Alexandria Hammond (Analysts)

Good morning, everybody. My name is Alex Hammond, and I'm the biopharma analyst here at Wolfe.

So it's my pleasure today to

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Johnson & Johnson

24/01	Argus Raises Price Target on Johnson & Johnson to $240 From $210	MT
23/01	Bernstein Adjusts Price Target on Johnson & Johnson to $225 From $208, Maintains Market Perform Rating	MT
23/01	Guggenheim Adjusts Price Target on Johnson & Johnson to $240 From $227, Maintains Buy Rating	MT
22/01	Johnson & Johnson Reports Modest Q4 Beat but Stock Seems Fairly Valued, Morgan Stanley Says	MT
22/01	Goldman Sachs Adjusts Price Target on Johnson & Johnson to $250 From $240, Maintains Buy Rating	MT
22/01	Leerink Partners Adjusts Price Target on Johnson & Johnson to $232 From $201, Maintains Market Perform Rating	MT
22/01	Raymond James Adjusts Price Target on Johnson & Johnson to $237 From $209, Maintains Outperform Rating	MT
22/01	Wolfe Research Adjusts Price Target on Johnson & Johnson to $260 From $240, Maintains Outperform Rating	MT
22/01	Scotiabank Adjusts Price Target on Johnson & Johnson to $265 From $230, Maintains Sector Outperform Rating	MT
22/01	Stifel Adjusts Price Target on Johnson & Johnson to $220 From $205, Maintains Hold Rating	MT
22/01	JPMorgan Adjusts Price Target on Johnson & Johnson to $225 From $205, Maintains Neutral Rating	MT
22/01	Citigroup Adjusts Price Target on Johnson & Johnson to $250 From $232, Maintains Buy Rating	MT
22/01	TD Cowen Adjusts Price Target on Johnson & Johnson to $250 From $222, Maintains Buy Rating	MT
22/01	Morgan Stanley Adjusts Price Target on Johnson & Johnson to $200 From $197, Maintains Equalweight Rating	MT
22/01	Wells Fargo Adjusts Price Target on Johnson & Johnson to $240 From $230, Maintains Overweight Rating	MT
22/01	Morgan Stanley Raises Price Target on Johnson & Johnson to $200 From $197, Keeps Equalweight Rating	MT
22/01	Health Care Up After Trump Rescinds Tariff Threats - Health Care Roundup	DJ
22/01	Sector Update: Health Care Stocks Higher Late Afternoon	MT
22/01	Wall Street jumps on Greenland framework deal	RE
22/01	Sector Update: Health Care Stocks Rise in Afternoon Trading	MT
21/01	Sector Update: Health Care	MT
21/01	Top Midday Stories: Trump Says US Doesn't Want to Use Force to Acquire Greenland; Netflix Shares Fall on Low Q1 Guidance	MT
21/01	Wall Street regains momentum as Trump speaks at Davos
21/01	Johnson & Johnson, Q4 2025 Earnings Call, Jan 21, 2026
21/01	Global markets live: Netflix, OpenAI, Nvidia, Meta, Alibaba, Netflix…